Cargando…

4084 Predictors of mortality among non-severe hemophilia A patients in the United States

OBJECTIVES/GOALS: To determine predictors of mortality in non-severe hemophilia A (NSHA) patients. METHODS/STUDY POPULATION: The ATHNdataset was used to identify NSHA patients who have authorized the sharing of their demographic and clinical information for research. Factors examined included race,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Ming Y, Cheng, Dunlei, Key, Nigel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822992/
http://dx.doi.org/10.1017/cts.2020.139
_version_ 1784646719870337024
author Lim, Ming Y
Cheng, Dunlei
Key, Nigel
author_facet Lim, Ming Y
Cheng, Dunlei
Key, Nigel
author_sort Lim, Ming Y
collection PubMed
description OBJECTIVES/GOALS: To determine predictors of mortality in non-severe hemophilia A (NSHA) patients. METHODS/STUDY POPULATION: The ATHNdataset was used to identify NSHA patients who have authorized the sharing of their demographic and clinical information for research. Factors examined included race, ethnicity, hemophilia severity, Hepatitis B, Hepatitis C and HIV infections. A mortality rate was calculated for each factors examined. The relative risk of death between patients in different categories of the factors was assessed by using the ratio of these mortality rates. To adjust for the effects of all of the studied factors with mortality, a multivariate analysis was performed using logistic regression. All hypothesis testing was two-tailed, with a significance level of .05. RESULTS/ANTICIPATED RESULTS: A total of 6,606 NSHA patients were followed for an average of 8.5 years. During 56,064 person years of observation, 136 (2.1%) NSHA patients died; 20% of deaths were malignancy-related. Mortality rates were similar across racial group. Hispanic patients were 60% less likely to die than non-Hispanic patients (p = 0.006). Patients with Hepatitis C infection and HIV infection were 7 times as likely to die compared to those without infections (p<0.001). After adjusting for the effects of all examined factors in a multivariate analysis, patients with hepatitis C and HIV infection remain significantly associated with increased mortality at 6.1 times and 3.6 times the risk, respectively. DISCUSSION/SIGNIFICANCE OF IMPACT: Despite significant improvement in the therapeutic approaches for infectious diseases, Hepatitis C and HIV infections remain strong predictors of mortality in this NSHA cohort. CONFLICT OF INTEREST DESCRIPTION: N/A.
format Online
Article
Text
id pubmed-8822992
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-88229922022-02-18 4084 Predictors of mortality among non-severe hemophilia A patients in the United States Lim, Ming Y Cheng, Dunlei Key, Nigel J Clin Transl Sci Clinical Epidemiology/Clinical Trial OBJECTIVES/GOALS: To determine predictors of mortality in non-severe hemophilia A (NSHA) patients. METHODS/STUDY POPULATION: The ATHNdataset was used to identify NSHA patients who have authorized the sharing of their demographic and clinical information for research. Factors examined included race, ethnicity, hemophilia severity, Hepatitis B, Hepatitis C and HIV infections. A mortality rate was calculated for each factors examined. The relative risk of death between patients in different categories of the factors was assessed by using the ratio of these mortality rates. To adjust for the effects of all of the studied factors with mortality, a multivariate analysis was performed using logistic regression. All hypothesis testing was two-tailed, with a significance level of .05. RESULTS/ANTICIPATED RESULTS: A total of 6,606 NSHA patients were followed for an average of 8.5 years. During 56,064 person years of observation, 136 (2.1%) NSHA patients died; 20% of deaths were malignancy-related. Mortality rates were similar across racial group. Hispanic patients were 60% less likely to die than non-Hispanic patients (p = 0.006). Patients with Hepatitis C infection and HIV infection were 7 times as likely to die compared to those without infections (p<0.001). After adjusting for the effects of all examined factors in a multivariate analysis, patients with hepatitis C and HIV infection remain significantly associated with increased mortality at 6.1 times and 3.6 times the risk, respectively. DISCUSSION/SIGNIFICANCE OF IMPACT: Despite significant improvement in the therapeutic approaches for infectious diseases, Hepatitis C and HIV infections remain strong predictors of mortality in this NSHA cohort. CONFLICT OF INTEREST DESCRIPTION: N/A. Cambridge University Press 2020-07-29 /pmc/articles/PMC8822992/ http://dx.doi.org/10.1017/cts.2020.139 Text en © The Association for Clinical and Translational Science 2020 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Epidemiology/Clinical Trial
Lim, Ming Y
Cheng, Dunlei
Key, Nigel
4084 Predictors of mortality among non-severe hemophilia A patients in the United States
title 4084 Predictors of mortality among non-severe hemophilia A patients in the United States
title_full 4084 Predictors of mortality among non-severe hemophilia A patients in the United States
title_fullStr 4084 Predictors of mortality among non-severe hemophilia A patients in the United States
title_full_unstemmed 4084 Predictors of mortality among non-severe hemophilia A patients in the United States
title_short 4084 Predictors of mortality among non-severe hemophilia A patients in the United States
title_sort 4084 predictors of mortality among non-severe hemophilia a patients in the united states
topic Clinical Epidemiology/Clinical Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822992/
http://dx.doi.org/10.1017/cts.2020.139
work_keys_str_mv AT limmingy 4084predictorsofmortalityamongnonseverehemophiliaapatientsintheunitedstates
AT chengdunlei 4084predictorsofmortalityamongnonseverehemophiliaapatientsintheunitedstates
AT keynigel 4084predictorsofmortalityamongnonseverehemophiliaapatientsintheunitedstates